Biogen

@biogen · Cambridge, MA · joined 14 Jun 2010

Official global newsroom account for Biogen, a leading biotech company pioneering innovative science since 1978. Community guidelines: https://t.co/56frPQHf74

44 754Followers

240Following

6 005Posts total

5.3KViews on collected posts

Son gönderiler

Biogen@biogen8 Sep

We’re heading to New Orleans for #PsychCongress2026! Together with Supernus Pharmaceuticals, we’ll share the latest real-world evidence in postpartum depression (PPD). Attending? Connect with our team and visit us at booth 1041. Learn more: https://t.co/ovR8Cctz5v https://t.co/

0:05

862 views · 2 likes · 1 reposts · 0 replies Open on X →

Biogen@biogen4 Sep

At #EEC2026 we’re sharing the latest data from our investigational study for Dravet syndrome, exploring the disease’s underlying genetic cause. Stop by booth #38 and join us at our medical symposium to learn more about our work in this genetic and highly burdensome disease. https

0:05

738 views · 6 likes · 2 reposts · 1 replies Open on X →

Biogen@biogen4 Sep

#News: With @StokeTx we’re presenting data on an investigational drug for Dravet syndrome at #EEC2026. Read more about these data: https://t.co/l2wvGQCJgf https://t.co/hpTWuAJeZl

0:07

855 views · 4 likes · 2 reposts · 0 replies Open on X →

Biogen@biogen1 Sep

#News: We are attending #EEC2026 alongside @StokeTx to share our latest findings in Dravet syndrome. Read more about our upcoming presentations: https://t.co/urGonuDk89 https://t.co/LJcvgbKEZy

0:07

850 views · 3 likes · 0 reposts · 0 replies Open on X →

Biogen@biogen7 Aug

@biogen Well-placed addition. Small molecules are a useful complement to the biologics side of the pipeline. 19 views · 0 likes · 0 reposts · 0 replies Open on X →

Biogen@biogen6 Aug

#News: We announced the completion of the acquisition of RayThera Inc. This acquisition marks another step in growing Biogen’s immunology portfolio, adding multiple potential assets for immune-mediated diseases. Read more: https://t.co/YfMJt4mD0g https://t.co/DBbugCeOTC

0:10

2K views · 9 likes · 3 reposts · 3 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 6 gönderi, 10K–100K takipçi aralığıyla yan yana. hem erişimde hem etkileşimde benzerlerinin altında.

Medyan görüntülenme852bu hesap92410K–100K için medyan

Erişim, %1.90%bu hesap3.62%10K–100K için medyan

Etkileşim, %0.53%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	852	924	0.92×
Erişim (görüntülenme ÷ takipçi)	1.90%	3.62%	0.53×
Etkileşim oranı	0.53%	1.52%	0.35×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2K6 Aug

197 Aug

8501 Sep

8554 Sep

738

8628 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.80%6 Aug

0.00%7 Aug

0.35%1 Sep

0.70%4 Sep

1.22%

0.35%8 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.9%24 in total

Reposts21.6%8 in total

Replies10.8%4 in total

Quotes2.7%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.